img

Global Hemorrhagic Septicemia Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hemorrhagic Septicemia Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Haemorrhagic septicaemia (HS), an economically important disease of cattle and buffaloes, is caused by Pasteurella multocida (6B).
Hemorrhagic Septicemia Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hemorrhagic Septicemia Vaccines market is projected to reach US$ 440.3 million in 2029, increasing from US$ 315 million in 2022, with the CAGR of 4.3% during the period of 2024 to 2029. Demand from Cattle and Buffaloes are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hemorrhagic Septicemia Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bio-Labs (PVT) Limited
Brilliant Bio Pharma
C.A. Laboratorios Asociados (CALA)
Ceva Santé Animale
Vecol
FATRO
Indian Immunologicals Limited
Institute of Animal Health and Veterinary Biologicals
Institute of Veterinary Preventive Medicine
Intervac (PVT) Ltd
LABIOFAM
Laboratorios Laverlam
Laboratorios Ovejero
Limor de Colombia
National Veterinary Research Institute
Zoetis
Segment by Type
Oil–adjuvant Vaccines
Aluminum hydroxide-adjuvant Vaccines

Segment by Application


Cattle
Buffaloes

Segment by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hemorrhagic Septicemia Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hemorrhagic Septicemia Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hemorrhagic Septicemia Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hemorrhagic Septicemia Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hemorrhagic Septicemia Vaccines introduction, etc. Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Hemorrhagic Septicemia Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Hemorrhagic Septicemia Vaccines Market Overview
1.1 Hemorrhagic Septicemia Vaccines Product Overview
1.2 Hemorrhagic Septicemia Vaccines Market Segment by Type
1.2.1 Oil–adjuvant Vaccines
1.2.2 Aluminum hydroxide-adjuvant Vaccines
1.3 Global Hemorrhagic Septicemia Vaccines Market Size by Type
1.3.1 Global Hemorrhagic Septicemia Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Hemorrhagic Septicemia Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Hemorrhagic Septicemia Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hemorrhagic Septicemia Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Hemorrhagic Septicemia Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Hemorrhagic Septicemia Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Hemorrhagic Septicemia Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Hemorrhagic Septicemia Vaccines Sales Breakdown by Type (2018-2024)
2 Global Hemorrhagic Septicemia Vaccines Market Competition by Company
2.1 Global Top Players by Hemorrhagic Septicemia Vaccines Sales (2018-2024)
2.2 Global Top Players by Hemorrhagic Septicemia Vaccines Revenue (2018-2024)
2.3 Global Top Players by Hemorrhagic Septicemia Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Hemorrhagic Septicemia Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hemorrhagic Septicemia Vaccines Market Competitive Situation and Trends
2.5.1 Hemorrhagic Septicemia Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Hemorrhagic Septicemia Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hemorrhagic Septicemia Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Hemorrhagic Septicemia Vaccines Market
2.8 Key Manufacturers Hemorrhagic Septicemia Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hemorrhagic Septicemia Vaccines Status and Outlook by Region
3.1 Global Hemorrhagic Septicemia Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hemorrhagic Septicemia Vaccines Historic Market Size by Region
3.2.1 Global Hemorrhagic Septicemia Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Hemorrhagic Septicemia Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Hemorrhagic Septicemia Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Hemorrhagic Septicemia Vaccines Forecasted Market Size by Region
3.3.1 Global Hemorrhagic Septicemia Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Hemorrhagic Septicemia Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Hemorrhagic Septicemia Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hemorrhagic Septicemia Vaccines by Application
4.1 Hemorrhagic Septicemia Vaccines Market Segment by Application
4.1.1 Cattle
4.1.2 Buffaloes
4.2 Global Hemorrhagic Septicemia Vaccines Market Size by Application
4.2.1 Global Hemorrhagic Septicemia Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Hemorrhagic Septicemia Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Hemorrhagic Septicemia Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hemorrhagic Septicemia Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Hemorrhagic Septicemia Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Hemorrhagic Septicemia Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Hemorrhagic Septicemia Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Hemorrhagic Septicemia Vaccines Sales Breakdown by Application (2018-2024)
5 North America Hemorrhagic Septicemia Vaccines by Country
5.1 North America Hemorrhagic Septicemia Vaccines Historic Market Size by Country
5.1.1 North America Hemorrhagic Septicemia Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hemorrhagic Septicemia Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Hemorrhagic Septicemia Vaccines Sales in Value by Country (2018-2024)
5.2 North America Hemorrhagic Septicemia Vaccines Forecasted Market Size by Country
5.2.1 North America Hemorrhagic Septicemia Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Hemorrhagic Septicemia Vaccines Sales in Value by Country (2024-2029)
6 Europe Hemorrhagic Septicemia Vaccines by Country
6.1 Europe Hemorrhagic Septicemia Vaccines Historic Market Size by Country
6.1.1 Europe Hemorrhagic Septicemia Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hemorrhagic Septicemia Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Hemorrhagic Septicemia Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Hemorrhagic Septicemia Vaccines Forecasted Market Size by Country
6.2.1 Europe Hemorrhagic Septicemia Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Hemorrhagic Septicemia Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Hemorrhagic Septicemia Vaccines by Region
7.1 Asia-Pacific Hemorrhagic Septicemia Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Hemorrhagic Septicemia Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hemorrhagic Septicemia Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Hemorrhagic Septicemia Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Hemorrhagic Septicemia Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Hemorrhagic Septicemia Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hemorrhagic Septicemia Vaccines Sales in Value by Region (2024-2029)
8 Latin America Hemorrhagic Septicemia Vaccines by Country
8.1 Latin America Hemorrhagic Septicemia Vaccines Historic Market Size by Country
8.1.1 Latin America Hemorrhagic Septicemia Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hemorrhagic Septicemia Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Hemorrhagic Septicemia Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Hemorrhagic Septicemia Vaccines Forecasted Market Size by Country
8.2.1 Latin America Hemorrhagic Septicemia Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hemorrhagic Septicemia Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Hemorrhagic Septicemia Vaccines by Country
9.1 Middle East and Africa Hemorrhagic Septicemia Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Hemorrhagic Septicemia Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hemorrhagic Septicemia Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Hemorrhagic Septicemia Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Hemorrhagic Septicemia Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Hemorrhagic Septicemia Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hemorrhagic Septicemia Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bio-Labs (PVT) Limited
10.1.1 Bio-Labs (PVT) Limited Company Information
10.1.2 Bio-Labs (PVT) Limited Introduction and Business Overview
10.1.3 Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Products Offered
10.1.5 Bio-Labs (PVT) Limited Recent Development
10.2 Brilliant Bio Pharma
10.2.1 Brilliant Bio Pharma Company Information
10.2.2 Brilliant Bio Pharma Introduction and Business Overview
10.2.3 Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Products Offered
10.2.5 Brilliant Bio Pharma Recent Development
10.3 C.A. Laboratorios Asociados (CALA)
10.3.1 C.A. Laboratorios Asociados (CALA) Company Information
10.3.2 C.A. Laboratorios Asociados (CALA) Introduction and Business Overview
10.3.3 C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Products Offered
10.3.5 C.A. Laboratorios Asociados (CALA) Recent Development
10.4 Ceva Santé Animale
10.4.1 Ceva Santé Animale Company Information
10.4.2 Ceva Santé Animale Introduction and Business Overview
10.4.3 Ceva Santé Animale Hemorrhagic Septicemia Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Ceva Santé Animale Hemorrhagic Septicemia Vaccines Products Offered
10.4.5 Ceva Santé Animale Recent Development
10.5 Vecol
10.5.1 Vecol Company Information
10.5.2 Vecol Introduction and Business Overview
10.5.3 Vecol Hemorrhagic Septicemia Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Vecol Hemorrhagic Septicemia Vaccines Products Offered
10.5.5 Vecol Recent Development
10.6 FATRO
10.6.1 FATRO Company Information
10.6.2 FATRO Introduction and Business Overview
10.6.3 FATRO Hemorrhagic Septicemia Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 FATRO Hemorrhagic Septicemia Vaccines Products Offered
10.6.5 FATRO Recent Development
10.7 Indian Immunologicals Limited
10.7.1 Indian Immunologicals Limited Company Information
10.7.2 Indian Immunologicals Limited Introduction and Business Overview
10.7.3 Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Products Offered
10.7.5 Indian Immunologicals Limited Recent Development
10.8 Institute of Animal Health and Veterinary Biologicals
10.8.1 Institute of Animal Health and Veterinary Biologicals Company Information
10.8.2 Institute of Animal Health and Veterinary Biologicals Introduction and Business Overview
10.8.3 Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Products Offered
10.8.5 Institute of Animal Health and Veterinary Biologicals Recent Development
10.9 Institute of Veterinary Preventive Medicine
10.9.1 Institute of Veterinary Preventive Medicine Company Information
10.9.2 Institute of Veterinary Preventive Medicine Introduction and Business Overview
10.9.3 Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Products Offered
10.9.5 Institute of Veterinary Preventive Medicine Recent Development
10.10 Intervac (PVT) Ltd
10.10.1 Intervac (PVT) Ltd Company Information
10.10.2 Intervac (PVT) Ltd Introduction and Business Overview
10.10.3 Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Products Offered
10.10.5 Intervac (PVT) Ltd Recent Development
10.11 LABIOFAM
10.11.1 LABIOFAM Company Information
10.11.2 LABIOFAM Introduction and Business Overview
10.11.3 LABIOFAM Hemorrhagic Septicemia Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.11.4 LABIOFAM Hemorrhagic Septicemia Vaccines Products Offered
10.11.5 LABIOFAM Recent Development
10.12 Laboratorios Laverlam
10.12.1 Laboratorios Laverlam Company Information
10.12.2 Laboratorios Laverlam Introduction and Business Overview
10.12.3 Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Products Offered
10.12.5 Laboratorios Laverlam Recent Development
10.13 Laboratorios Ovejero
10.13.1 Laboratorios Ovejero Company Information
10.13.2 Laboratorios Ovejero Introduction and Business Overview
10.13.3 Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Products Offered
10.13.5 Laboratorios Ovejero Recent Development
10.14 Limor de Colombia
10.14.1 Limor de Colombia Company Information
10.14.2 Limor de Colombia Introduction and Business Overview
10.14.3 Limor de Colombia Hemorrhagic Septicemia Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Limor de Colombia Hemorrhagic Septicemia Vaccines Products Offered
10.14.5 Limor de Colombia Recent Development
10.15 National Veterinary Research Institute
10.15.1 National Veterinary Research Institute Company Information
10.15.2 National Veterinary Research Institute Introduction and Business Overview
10.15.3 National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.15.4 National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Products Offered
10.15.5 National Veterinary Research Institute Recent Development
10.16 Zoetis
10.16.1 Zoetis Company Information
10.16.2 Zoetis Introduction and Business Overview
10.16.3 Zoetis Hemorrhagic Septicemia Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Zoetis Hemorrhagic Septicemia Vaccines Products Offered
10.16.5 Zoetis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hemorrhagic Septicemia Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hemorrhagic Septicemia Vaccines Industrial Chain Analysis
11.4 Hemorrhagic Septicemia Vaccines Market Dynamics
11.4.1 Hemorrhagic Septicemia Vaccines Industry Trends
11.4.2 Hemorrhagic Septicemia Vaccines Market Drivers
11.4.3 Hemorrhagic Septicemia Vaccines Market Challenges
11.4.4 Hemorrhagic Septicemia Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hemorrhagic Septicemia Vaccines Distributors
12.3 Hemorrhagic Septicemia Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Oil–adjuvant Vaccines
Table 2. Major Company of Aluminum hydroxide-adjuvant Vaccines
Table 3. Global Hemorrhagic Septicemia Vaccines Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Hemorrhagic Septicemia Vaccines Sales by Type (2018-2024) & (M Units)
Table 5. Global Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Hemorrhagic Septicemia Vaccines Sales by Type (2018-2024) & (US& Million)
Table 7. Global Hemorrhagic Septicemia Vaccines Market Share in Value by Type (2018-2024)
Table 8. Global Hemorrhagic Septicemia Vaccines Price by Type (2018-2024) & (USD/K Unit)
Table 9. Global Hemorrhagic Septicemia Vaccines Sales by Type (2024-2029) & (M Units)
Table 10. Global Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Hemorrhagic Septicemia Vaccines Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Type (2024-2029)
Table 13. Global Hemorrhagic Septicemia Vaccines Price by Type (2024-2029) & (USD/K Unit)
Table 14. North America Hemorrhagic Septicemia Vaccines Sales by Type (2018-2024) & (M Units)
Table 15. North America Hemorrhagic Septicemia Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Hemorrhagic Septicemia Vaccines Sales (M Units) by Type (2018-2024)
Table 17. Europe Hemorrhagic Septicemia Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales (M Units) by Type (2018-2024)
Table 19. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Hemorrhagic Septicemia Vaccines Sales (M Units) by Type (2018-2024)
Table 21. Latin America Hemorrhagic Septicemia Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Hemorrhagic Septicemia Vaccines Sales (M Units) by Type (2018-2024)
Table 23. Middle East and Africa Hemorrhagic Septicemia Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Hemorrhagic Septicemia Vaccines Sales by Company (2018-2024) & (M Units)
Table 25. Global Hemorrhagic Septicemia Vaccines Sales Share by Company (2018-2024)
Table 26. Global Hemorrhagic Septicemia Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Hemorrhagic Septicemia Vaccines Revenue Share by Company (2018-2024)
Table 28. Global Market Hemorrhagic Septicemia Vaccines Price by Company (2018-2024) & (USD/K Unit)
Table 29. Global Hemorrhagic Septicemia Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Hemorrhagic Septicemia Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hemorrhagic Septicemia Vaccines as of 2022)
Table 32. Date of Key Manufacturers Enter into Hemorrhagic Septicemia Vaccines Market
Table 33. Key Manufacturers Hemorrhagic Septicemia Vaccines Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Hemorrhagic Septicemia Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Hemorrhagic Septicemia Vaccines Sales by Region (2018-2024) & (M Units)
Table 37. Global Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Hemorrhagic Septicemia Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Region (2018-2024)
Table 40. Global Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 41. Global Hemorrhagic Septicemia Vaccines Sales by Region (2024-2029) & (M Units)
Table 42. Global Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Hemorrhagic Septicemia Vaccines Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Region (2024-2029)
Table 45. Global Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2024-2029)
Table 46. Global Hemorrhagic Septicemia Vaccines Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Hemorrhagic Septicemia Vaccines Sales by Application (2018-2024) & (M Units)
Table 48. Global Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Hemorrhagic Septicemia Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Application (2018-2024)
Table 51. Global Hemorrhagic Septicemia Vaccines Price by Application (2018-2024) & (USD/K Unit)
Table 52. Global Hemorrhagic Septicemia Vaccines Sales by Application (2024-2029) & (M Units)
Table 53. Global Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Hemorrhagic Septicemia Vaccines Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Application (2024-2029)
Table 56. Global Hemorrhagic Septicemia Vaccines Price by Application (2024-2029) & (USD/K Unit)
Table 57. North America Hemorrhagic Septicemia Vaccines Sales by Application (2018-2024) (M Units)
Table 58. North America Hemorrhagic Septicemia Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Hemorrhagic Septicemia Vaccines Sales by Application (2018-2024) (M Units)
Table 60. Europe Hemorrhagic Septicemia Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales by Application (2018-2024) (M Units)
Table 62. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Hemorrhagic Septicemia Vaccines Sales by Application (2018-2024) (M Units)
Table 64. Latin America Hemorrhagic Septicemia Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Hemorrhagic Septicemia Vaccines Sales by Application (2018-2024) (M Units)
Table 66. Middle East and Africa Hemorrhagic Septicemia Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Hemorrhagic Septicemia Vaccines Sales by Country (2018-2024) & (M Units)
Table 68. North America Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Hemorrhagic Septicemia Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Country (2018-2024)
Table 71. North America Hemorrhagic Septicemia Vaccines Sales by Country (2024-2029) & (M Units)
Table 72. North America Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Hemorrhagic Septicemia Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Hemorrhagic Septicemia Vaccines Sales by Country (2018-2024) & (M Units)
Table 76. Europe Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Hemorrhagic Septicemia Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Hemorrhagic Septicemia Vaccines Sales by Country (2024-2029) & (M Units)
Table 80. Europe Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Hemorrhagic Septicemia Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales by Region (2018-2024) & (M Units)
Table 84. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales by Region (2024-2029) & (M Units)
Table 88. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Hemorrhagic Septicemia Vaccines Sales by Country (2018-2024) & (M Units)
Table 92. Latin America Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Hemorrhagic Septicemia Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Hemorrhagic Septicemia Vaccines Sales by Country (2024-2029) & (M Units)
Table 96. Latin America Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Hemorrhagic Septicemia Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Hemorrhagic Septicemia Vaccines Sales by Country (2018-2024) & (M Units)
Table 100. Middle East and Africa Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Hemorrhagic Septicemia Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Hemorrhagic Septicemia Vaccines Sales by Country (2024-2029) & (M Units)
Table 104. Middle East and Africa Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Hemorrhagic Septicemia Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Country (2024-2029)
Table 107. Bio-Labs (PVT) Limited Company Information
Table 108. Bio-Labs (PVT) Limited Introduction and Business Overview
Table 109. Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 110. Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Product
Table 111. Bio-Labs (PVT) Limited Recent Development
Table 112. Brilliant Bio Pharma Company Information
Table 113. Brilliant Bio Pharma Introduction and Business Overview
Table 114. Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 115. Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Product
Table 116. Brilliant Bio Pharma Recent Development
Table 117. C.A. Laboratorios Asociados (CALA) Company Information
Table 118. C.A. Laboratorios Asociados (CALA) Introduction and Business Overview
Table 119. C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 120. C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Product
Table 121. C.A. Laboratorios Asociados (CALA) Recent Development
Table 122. Ceva Santé Animale Company Information
Table 123. Ceva Santé Animale Introduction and Business Overview
Table 124. Ceva Santé Animale Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 125. Ceva Santé Animale Hemorrhagic Septicemia Vaccines Product
Table 126. Ceva Santé Animale Recent Development
Table 127. Vecol Company Information
Table 128. Vecol Introduction and Business Overview
Table 129. Vecol Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 130. Vecol Hemorrhagic Septicemia Vaccines Product
Table 131. Vecol Recent Development
Table 132. FATRO Company Information
Table 133. FATRO Introduction and Business Overview
Table 134. FATRO Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 135. FATRO Hemorrhagic Septicemia Vaccines Product
Table 136. FATRO Recent Development
Table 137. Indian Immunologicals Limited Company Information
Table 138. Indian Immunologicals Limited Introduction and Business Overview
Table 139. Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 140. Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Product
Table 141. Indian Immunologicals Limited Recent Development
Table 142. Institute of Animal Health and Veterinary Biologicals Company Information
Table 143. Institute of Animal Health and Veterinary Biologicals Introduction and Business Overview
Table 144. Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 145. Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Product
Table 146. Institute of Animal Health and Veterinary Biologicals Recent Development
Table 147. Institute of Veterinary Preventive Medicine Company Information
Table 148. Institute of Veterinary Preventive Medicine Introduction and Business Overview
Table 149. Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 150. Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Product
Table 151. Institute of Veterinary Preventive Medicine Recent Development
Table 152. Intervac (PVT) Ltd Company Information
Table 153. Intervac (PVT) Ltd Introduction and Business Overview
Table 154. Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 155. Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Product
Table 156. Intervac (PVT) Ltd Recent Development
Table 157. LABIOFAM Company Information
Table 158. LABIOFAM Introduction and Business Overview
Table 159. LABIOFAM Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 160. LABIOFAM Hemorrhagic Septicemia Vaccines Product
Table 161. LABIOFAM Recent Development
Table 162. Laboratorios Laverlam Company Information
Table 163. Laboratorios Laverlam Introduction and Business Overview
Table 164. Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 165. Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Product
Table 166. Laboratorios Laverlam Recent Development
Table 167. Laboratorios Ovejero Company Information
Table 168. Laboratorios Ovejero Introduction and Business Overview
Table 169. Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 170. Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Product
Table 171. Laboratorios Ovejero Recent Development
Table 172. Limor de Colombia Company Information
Table 173. Limor de Colombia Introduction and Business Overview
Table 174. Limor de Colombia Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 175. Limor de Colombia Hemorrhagic Septicemia Vaccines Product
Table 176. Limor de Colombia Recent Development
Table 177. National Veterinary Research Institute Company Information
Table 178. National Veterinary Research Institute Introduction and Business Overview
Table 179. National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 180. National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Product
Table 181. National Veterinary Research Institute Recent Development
Table 182. Zoetis Company Information
Table 183. Zoetis Introduction and Business Overview
Table 184. Zoetis Hemorrhagic Septicemia Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 185. Zoetis Hemorrhagic Septicemia Vaccines Product
Table 186. Zoetis Recent Development
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Hemorrhagic Septicemia Vaccines Market Trends
Table 190. Hemorrhagic Septicemia Vaccines Market Drivers
Table 191. Hemorrhagic Septicemia Vaccines Market Challenges
Table 192. Hemorrhagic Septicemia Vaccines Market Restraints
Table 193. Hemorrhagic Septicemia Vaccines Distributors List
Table 194. Hemorrhagic Septicemia Vaccines Downstream Customers
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemorrhagic Septicemia Vaccines Product Picture
Figure 2. Global Hemorrhagic Septicemia Vaccines Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Hemorrhagic Septicemia Vaccines Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Hemorrhagic Septicemia Vaccines Sales Status and Outlook (2018-2029) & (M Units)
Figure 5. Product Picture of Oil–adjuvant Vaccines
Figure 6. Global Oil–adjuvant Vaccines Sales YoY Growth (2018-2029) & (M Units)
Figure 7. Product Picture of Aluminum hydroxide-adjuvant Vaccines
Figure 8. Global Aluminum hydroxide-adjuvant Vaccines Sales YoY Growth (2018-2029) & (M Units)
Figure 9. Global Hemorrhagic Septicemia Vaccines Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Type in 2022 & 2029
Figure 11. North America Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Type in 2022
Figure 12. North America Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Type in 2022
Figure 13. Europe Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. Europe Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Latin America Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Hemorrhagic Septicemia Vaccines Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Hemorrhagic Septicemia Vaccines Revenue in 2022
Figure 23. Hemorrhagic Septicemia Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Cattle
Figure 25. Global Cattle Sales YoY Growth (2018-2029) & (M Units)
Figure 26. Product Picture of Buffaloes
Figure 27. Global Buffaloes Sales YoY Growth (2018-2029) & (M Units)
Figure 28. Global Hemorrhagic Septicemia Vaccines Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Application in 2022 & 2029
Figure 30. North America Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Application in 2022
Figure 31. North America Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Application in 2022
Figure 32. Europe Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Application in 2022
Figure 33. Europe Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Latin America Hemorrhagic Septicemia Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Hemorrhagic Septicemia Vaccines Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Hemorrhagic Septicemia Vaccines Manufacturing Cost Structure
Figure 41. Hemorrhagic Septicemia Vaccines Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed